Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a ginkgo supplement beat stress and boost memory?

NCT ID NCT06583941

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a dietary supplement called Virtiva Plus, which contains ginkgo biloba, can help reduce stress and improve thinking in people aged 50 to 70 who feel stressed. Sixty participants took either a low or high dose twice daily for five weeks. Researchers measured anxiety, mood, memory, and quality of life using questionnaires and computer tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtiva Plus (dietary supplement with ginkgo biloba extract)
What this could lead to
If it works, this could point toward a natural supplement option for easing stress and supporting memory in midlife.
What could go wrong
This is a small, completed study with only 60 participants. Results may not apply to everyone, and supplements can have side effects or interact with medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * Aged 50 to 70 years (both limits inclusive) * Body mass index (BMI) value of 18.5-29.99 kg/m2 * Willing and able to give written informed consent * Able to read, understand, sign and date the informed consent document (English only) * Able and willing to comply with the schedule visit(s) and study requirements. * Willing to consume the investigational study product 2 times per day for 5 weeks. * Willing to maintain a habitual diet and avoid changes during the study period (for example, intermittent fasting, ketogenic diet, Atkins diet, meatless diet, etc.). * Willing to cease from consuming cognitive enhancement supplements 7 days prior to and after the study commencement, until the end of the study. Exclusion Criteria: * Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirements and/or record the necessary study measurements. * History of cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other) * History of neurological disorders (Parkinson's, Amyotrophic lateral sclerosis, epilepsy, spinal cord injury resulting in inability to use upper extremities, other) * History of gastrointestinal disorders that could lead to uncertain absorption of the study supplements, (i.e., inflammatory bowel disease, ulcerative colitis, Crohn's disease, colostomy, or eating disorder) * History of kidney or liver disease * History of metabolic disorders (diabetes, metabolic syndrome, other) * History or current malignancy * Receiving chemotherapy agents or radiation treatments * Diagnosis of a terminal illness * Pregnancy or has breast fed within 3 months prior to enrollment * Use of prescription medications that impact digestion (i.e., proton pump inhibitor medications, other) * History or current alcohol or drug abuse * Has significant concurrent illnesses (controlled or uncontrolled), such as lupus, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such condition might be aggravated as a result of treatment * The investigator feels that for any reason the subject is not eligible to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive change are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Applied Science and Performance Institute

    Tampa, Florida, 33634, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.